Charles River Laboratories International Inc (NYSE:CRL) Share Price

Company Profile

Business description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact
251 Ballardvale Street
WilmingtonMA01887
USA
T: +1 781 222-6000
E: [email protected]
https://www.criver.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
20,100

Recommended

I catch up with Shane Ponraj after an eventful reporting season for healthcare major CSL.

Joseph Taylor | 26 August 2025

Pandemic related tailwinds are a distant memory for Reece, which looks set to face more competition in Australia.

Esther Holloway | 26 August 2025

Tesla’s challenges echo past issues the company has overcome, says Zevenbergen’s Joe Dennison.

Gabe Alpert | 25 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,222.30	6.20	-0.07%
CAC 40	7,709.81	133.23	-1.70%
DAX 40	24,152.87	120.25	-0.50%
Dow JONES (US)	45,418.07	135.60	0.30%
FTSE 100	9,265.80	55.60	-0.60%
HKSE	25,521.73	3.19	-0.01%
NASDAQ	21,544.27	94.98	0.44%
Nikkei 225	42,529.95	135.55	0.32%
NZX 50 Index	12,919.78	38.20	-0.29%
S&P 500	6,465.94	26.62	0.41%
S&P/ASX 200	8,953.60	7.60	-0.08%
SSE Composite Index	3,865.16	3.22	-0.08%